Filter News
Area of Research
- (-) Materials for Computing (3)
- (-) Nuclear Science and Technology (2)
- Advanced Manufacturing (1)
- Biology and Environment (27)
- Clean Energy (52)
- Climate and Environmental Systems (1)
- Computational Engineering (1)
- Computer Science (1)
- Fusion and Fission (1)
- Isotopes (2)
- Materials (34)
- National Security (4)
- Neutron Science (11)
- Supercomputing (27)
News Topics
- (-) Bioenergy (1)
- (-) Biomedical (2)
- (-) Composites (1)
- (-) Energy Storage (2)
- (-) Environment (1)
- 3-D Printing/Advanced Manufacturing (4)
- Advanced Reactors (2)
- Chemical Sciences (2)
- Computer Science (3)
- Decarbonization (1)
- Fusion (1)
- Isotopes (3)
- Materials (2)
- Materials Science (6)
- Microscopy (1)
- Nanotechnology (1)
- National Security (1)
- Neutron Science (3)
- Nuclear Energy (7)
- Physics (1)
- Polymers (4)
- Quantum Science (1)
- Security (1)
- Space Exploration (3)
- Summit (1)
- Sustainable Energy (3)
- Transformational Challenge Reactor (1)
- Transportation (2)
Media Contacts
Researchers at ORNL designed a novel polymer to bind and strengthen silica sand for binder jet additive manufacturing, a 3D-printing method used by industries for prototyping and part production.
Oak Ridge National Laboratory researchers have developed a new family of cathodes with the potential to replace the costly cobalt-based cathodes typically found in today’s lithium-ion batteries that power electric vehicles and consumer electronics.
Four research teams from the Department of Energy’s Oak Ridge National Laboratory and their technologies have received 2020 R&D 100 Awards.
The combination of bioenergy with carbon capture and storage could cost-effectively sequester hundreds of millions of metric tons per year of carbon dioxide in the United States, making it a competitive solution for carbon management, according to a new analysis by ORNL scientists.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.